172 related articles for article (PubMed ID: 34844771)
1. Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine.
Kuriyama K; Kitamura Y; Tsuji T; Nishikawa R; Nagata H; Ohshiro M; Sugitani M; Hirakawa Y; Matsumoto Y; Iwai T; Uchiyama H
Curr Probl Cancer; 2022 Apr; 46(2):100813. PubMed ID: 34844771
[TBL] [Abstract][Full Text] [Related]
2. Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.
Lee S; Yamauchi T; Ishii N; Hashimoto T; Kinoshita K; Imamura S; Kamiya K
Int J Hematol; 2017 Dec; 106(6):852-859. PubMed ID: 28791608
[TBL] [Abstract][Full Text] [Related]
3. Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans.
Hirano T; Higuchi Y; Yuki H; Hirata S; Nosaka K; Ishii N; Hashimoto T; Mitsuya H; Okuno Y
J Clin Exp Hematop; 2015; 55(2):83-8. PubMed ID: 26490520
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic pemphigus with bronchiolitis obliterans in a child.
Mar WA; Glaesser R; Struble K; Stephens-Groff S; Bangert J; Hansen RC
Pediatr Dermatol; 2003; 20(3):238-42. PubMed ID: 12787274
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and appearance of anti-BP180 antibodies in the late stage of the disease.
Kanaoka M; Matsukura S; Ishikawa H; Matsuura M; Ishii N; Hashimoto T; Aihara M
J Dermatol; 2014 Jul; 41(7):628-30. PubMed ID: 24985544
[TBL] [Abstract][Full Text] [Related]
7. [Follicular lymphoma accompanied by paraneoplastic pemphigus and bronchiolitis obliterans: a case report].
Watanabe K; Yoshifuji K; Saito T; Yamashita T; Nogami A; Sakashita C; Fukuda T; Arai A; Tohda S; Kawamata N; Miura O; Yamamoto M
Rinsho Ketsueki; 2019; 60(1):7-11. PubMed ID: 30726827
[TBL] [Abstract][Full Text] [Related]
8. [A case of follicular lymphoma complicated with lethal pemphigus].
Imataki O; Tamai Y; Abe Y; Ito I; Yoshikawa S; Kawakami K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic pemphigus occurs most commonly in indolent B cell lymphoma.
Morikawa K; Tsuji T; Yamasaki H; Egashira S; Kaguchi A; Kido M; Tsuda H
Acta Haematol; 2014; 132(1):73-4. PubMed ID: 24481059
[No Abstract] [Full Text] [Related]
10. Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease.
Chen W; Zhao L; Guo L; Zhao L; Niu H; Lian H; Dai H; Chen J; Wang C
Clin Respir J; 2022 Mar; 16(3):173-181. PubMed ID: 35060328
[TBL] [Abstract][Full Text] [Related]
11. Follicular lymphoma with paraneoplastic pemphigus as the first symptom: a case report and review of the literature.
Wu S; Gao D; Zhang Y; Yang P; Wang Y; Wang N; Xu J; Yu G
Int J Clin Exp Pathol; 2020; 13(7):1915-1923. PubMed ID: 32782723
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus.
Kikuchi T; Mori T; Shimizu T; Koda Y; Abe R; Kurihara Y; Funakoshi T; Yamagami J; Sato H; Tsunoda K; Amagai M; Okamoto S
Ann Hematol; 2017 Jul; 96(7):1221-1222. PubMed ID: 28447163
[No Abstract] [Full Text] [Related]
13. Paraneoplastic pemphigus associated with bronchiolitis obliterans.
Takahashi M; Shimatsu Y; Kazama T; Kimura K; Otsuka T; Hashimoto T
Chest; 2000 Feb; 117(2):603-7. PubMed ID: 10669715
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US.
Guzauskas GF; Masaquel A; Reyes C; Bernaards C; Krivasi T; Veenstra DL
J Med Econ; 2018 Oct; 21(10):960-967. PubMed ID: 29898619
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Pemphigus and Bronchiolitis Obliterans in a Patient with Splenic B-cell Lymphoma.
Wang SH; Chu CY; Chen HH; Chang YL; Chen KY; Chiu HC
J Formos Med Assoc; 2007 Sep; 106(9):768-73. PubMed ID: 17908666
[TBL] [Abstract][Full Text] [Related]
16. Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus.
Kishi T; Nakata J; Yamada T; Nakatsuka S; Matsuura A; Shibano M
Ann Hematol; 2022 Feb; 101(2):453-455. PubMed ID: 33754167
[No Abstract] [Full Text] [Related]
17. Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.
Cheson BD; Chua N; Mayer J; Dueck G; Trněný M; Bouabdallah K; Fowler N; Delwail V; Press O; Salles G; Gribben JG; Lennard A; Lugtenburg PJ; Fingerle-Rowson G; Mattiello F; Knapp A; Sehn LH
J Clin Oncol; 2018 Aug; 36(22):2259-2266. PubMed ID: 29584548
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway.
Haukaas FS; Ohna A; Krivasi T
Appl Health Econ Health Policy; 2018 Aug; 16(4):569-577. PubMed ID: 29923173
[TBL] [Abstract][Full Text] [Related]
19. [Factors associated with long-term survival in critically ill patients following surgery for solid tumors complicated with paraneoplastic pemphigus].
Pan JX; Zhu SN; Li SL; Wang DX
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):981-990. PubMed ID: 36241242
[TBL] [Abstract][Full Text] [Related]
20. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
Trotman J; Cheah CY; Marlton P; Opat S
Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
